submit to the journals

Heart Failure Journal Articles, Videos And Insights

Heart Failure:FEATURED Articles

flipper_slider

Heart Failure: Latest Articles

Heart Failure:FEATURED VIDEOS

Editor's choice

Dr Purvi Parwani (Assistant Professor of Medicine, Loma Linda University Health, Loma Linda, CA, USA), Professor Mamas Mamas (Professor of Cardiology, University of Keele, Keele, UK) and Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discuss social media in cardiology. Filmed at ESC 2018, Munich. View more content here. Speaker Disclosure: Dr Purvi Parwani, Professor Mamas Mamas and Dr Martha Gulati have nothing to disclose in relation to this video interview. Questions: "How did you get into social media?" (0:41) "How do you think that social media is evolving at conferences?" (1:15) "Social media has been used not only to advocate conferences but it's really changed our profession. There is a huge inequality, for example within women in cardiology - women are finding it increasingly difficult to get positions of leadership. How do you think social media has helped that?" (2.26) "Martha, a while ago you published a really nice paper around myocardial infarction in ladies, and there was a whole Twitter journal club around that. Do you see that's the way, going forwards, in dissemination of academic output?" (3:22) "How do you feel that in terms of education around imaging, social media has helped? (4:40) "How do you see the future of social media [...], how do you see it changing?" (5:25) "Do you see that there's a downside to social media in cardiology?" (6:28 touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Professor Jean-Claude Tardif (Montreal Heart Institute Research Centre and Professor of Medicine, University of Montreal, Montreal, Quebec, Canada) discusses the aims, rationale and recently released results of the COMMANDER-HF trial. Filmed at ESC 2018, Munich. View more content here. Speaker Disclosure: Professor Jean-Claude Tardif has the following disclosures in relation to this video interview: grants from Amarin, AstraZeneca, DalCor, Esperion, Ionis, Pfizer, Sanofi and Servier. Honoraria from DalCor, Pfizer, Sanofi, Servier. Minor equity interest in DalCor. Questions: 1. Please describe the key aims of the COMMANDER-HF trial of rivaroxaban? (0:08) 2. What do we already know about the efficacy and safety of rivaroxaban and what was the rationale behind the COMMANDER-HF trial? (1:05) 3. Which patient groups were eligible for inclusion in the COMMANDER-HF trial? (2:28) 4. What separates the COMMANDER-HF trial from previous trials of oral anticoagulants in heart failure? (3:01) 5. What were the lessons from the COMMANDER-HF trial? (3:39) touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.

Heart Failure:Latest Videos

Video List based on Category on Node Page

Latest Videos

Dr Purvi Parwani (Assistant Professor of Medicine, Loma Linda University Health, Loma Linda, CA, USA), Professor Mamas Mamas (Professor of Cardiology, University of Keele, Keele, UK) and Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discuss...
Professor Jean-Claude Tardif (Montreal Heart Institute Research Centre and Professor of Medicine, University of Montreal, Montreal, Quebec, Canada) discusses the aims, rationale and recently released results of the COMMANDER-HF trial. Filmed at ESC 2018, Munich. View more content here....
Professor Bernard Prendergast (Consultant Cardiologist, London Bridge Hospital, London, UK) discusses percutaneous mitral valve repair and mitral valve regurgitation, with particular emphasis on the results of the MITRA-FR trial and the MitraClip device. Filmed at ESC 2018, Munich. View more...
Haran Burri discusses how to assess the longevity of cardiac resynchronisation therapy based on real-life experience, and how his recent data be extrapolated to estimate the impact on the number of replacement procedure. He also discusses the impact of the results on patient morbidity and what may...
Pier Lambiase discusses patient selection for cardiac resynchronisation therapy and the current research into personalised computer models of the heart. Disclosures: Pier Lambiase has received research grants and speaker fees from Boston Scientific and educational grants from Medtronic and St...
Luca Bontempi discusses the challenges of resynchronisation therapy in the elderly along with some of the hot topics in cardiac rhythm management from this year’s meeting. FILMED AT THE CARDIOSTIM ANNUAL MEETING, JUNE 2016 WHAT ARE THE CHALLENGES OF RESYNCHRONISATION THERAPY IN THE...

LATEST TWEETS

Conference Highlights